• Site Map
  • PDF
  • Subscription
  • Register
  • LogIn
  • Site Map
  • PDF
  • Subscription
  • Register
  • LogIn
National
  • Politics
  • Inter-Korean summit 2018
  • Foreign Affairs
  • Embassy News
  • Defense Affairs
  • Foreign Communities
  • Investigations
  • Easy Korean
  • Oddly Enough
  • Diseases & welfare
  • Labor & environment
  • Education
  • Seoul & provinces
  • Obituaries
  • Photo News
Wed, April 25, 2018 | 11:36
      • North Korea
      • Entertainment
        • Music
        • Dramas & TV shows
        • Movies
        • Performances
        • Exhibitions
        • Photo News
      • Opinion
        • Editorial
        • Columnists
          • Park Moo-jong
          • Choi Sung-jin
          • Tong Kim
          • Lee Seong-hyon
          • Andrew Salmon
          • John Burton
          • Jason Lim
          • Donald Kirk
          • Kim Ji-myung
          • Michael Breen
          • Hyon O'Brien
          • Younghoy Kim Kimaro
          • Deauwand Myers
          • Bernard Rowan
          • Casey Lartigue, Jr.
          • Stephen Costello
          • Semoon Chang
          • Korean Historical Sense
        • Reporter's Notebook
        • Guest Column
        • Thoughts of the Times
        • Letter to the Editor
        • Times Forum
        • Cartoon
        • Today in History
      • Economy
        • Policies
        • Finance
        • Economic Essay Contest
        • Photo News
      • Biz & Tech
        • Automotive
        • IT
        • Heavy industries
        • Light industries
        • Science
        • Game
        • Photo News
      • National
        • Politics
        • Inter-Korean summit 2018
        • Foreign Affairs
        • Embassy News
        • Defense Affairs
        • Foreign Communities
        • Investigations
        • Easy Korean
        • Oddly Enough
        • Diseases & welfare
        • Labor & environment
        • Education
        • Seoul & provinces
        • Obituaries
        • Photo News
      • Culture
        • Books
        • Religions
        • Healthcare
        • Food
        • Fortune Telling
        • Hotel & Travel
        • Fashion
        • Korean Traditions
        • Trend
        • Photo News
      • Sports
        • Football
        • Baseball
        • Golf
        • Other Sports
        • 2018 PyeongChang
        • Photo News
      • World
        • SCMP
        • Asia Pacific
        • Americas
        • Europe
        • Middle East
        • Africa
      • Video
        • News
        • Feature
        • ShowBiz
      • Photos
      • Community
        • Time Forum
        • Market Place
        • Talk Box
        • Study Plaza
      • Learning English
    ---------------
    'RNL Bio smuggled out stem cells'
    Posted : 2013-01-03 19:40
    Updated : 2013-01-03 19:40
    By Yun Suh-young

    Stem cell research company RNL Bio faced allegations Thursday that it "smuggled" stem cells and related equipment overseas.

    According to multiple sources, the company sent 15.5 billion won worth of stem cells to hospitals in China and Japan on 860 different occasions from November 2008 through July 2012 without reporting the shipments to the Korea Customs Service (KCS).

    The company also allegedly smuggled out stem cell incubating batches worth 1.1 billion won to a Chinese corporation through a merchant.

    "The fact that the company has not reported the items to customs is true. The case has now been referred to the prosecution for further investigation," said an official from the KCS.

    Under the Customs Law, if a person sends items for business use overseas, they must report them to the customs.

    RNL Bio is also embroiled in controversy over introducing Korean patients to Japanese hospitals for stem cell therapy, which is highly restricted here.

    The company was criticized for exposing patients to potential risks arising from the treatment. Under the Korean Pharmaceutical Law, only stem cell treatment that has received approval after clinical testing is acceptable for use. In Japan, however, doctors are free to conduct operations with stem cells they have extracted from patients without approval from the health authorities.

    Prosecutors had been investigating the case after the Ministry of Health and Welfare referred the company to it for violating the Pharmaceutical Law in January last year. However, they halted the investigation in June following the company's filing of a complaint with the Constitutional Court.

    RNL Bio claimed the current law requiring researchers to receive certification for stem cell treatments after undergoing three rounds of clinical testing was a violation of the right to conduct research.

    The prosecution plans to restart its investigation dependent on the ruling from the Constitutional Court.

    The company did not give an immediate response to whether the allegations were true, but said it would release a public statement today.

    ysy@koreatimes.co.kr More articles by this reporter


     
     
    • South Korea reports first tick-borne disease death in 2018
    • Korean Air chief's wife allegedly harassing employees [VIDEO]
    • Two Koreans killed in Toronto van attack
    • Over 30 Chinese dead in North Korea tourist bus crash
    • Seoul to axe disposable umbrella covers
    • Cho family on the ropes
    • Jason Derulo's 'Colors' upsets Koreans with rising sun flag
    • Korean Air chief's wife under probe over assaults
    • Moon-Kim summit to begin Friday morning; end with official dinner
    • Kim's 'bitter sorrow' as bus crash kills 32 Chinese tourists [PHOTOS]
    • In preparation for Moon-Kim summit

    • Pink Run Marathon

    • Human rights chief meets Swiss envoy

    • Wish for successful hosting

    • You can take your hands off

    • Sophia in Seoul

    • Caught a whopper!

    • 2018 Imjin Classic

    • Torch relay at 'freedom village

    • Veterans association donates $10,000 to USFK

    Missile attack on Syria
     
    • About Korea Times
    • CEO Message
    • Times History
    • Contents Distribution
    • Media Kit
    • Contact Us
    • Location
    • Privacy Statement
    • Ombudsman
    • Mobile Service
    • PDF Service
    • RSS Service